- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03748641
전이성 전립선암 참가자의 치료를 위한 아비라테론 아세테이트 및 프레드니손과 아비라테론 아세테이트 및 프레드니손의 조합에 대한 니라파립의 연구 (MAGNITUDE)
전이성 전립선암 환자에서 아비라테론 아세테이트 및 프레드니손과 아비라테론 아세테이트 및 프레드니손을 병용한 니라파립 대 아비라테론 아세테이트 및 프레드니손의 3상 무작위, 위약 대조, 이중 맹검 연구
The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP and placebo.
연구 개요
상태
정황
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
-
Johannesburg, 남아프리카, 1619
- Clinresco Centres Pty Ltd
-
Pretoria, 남아프리카, 0001
- Clinical Research Unit
-
-
-
-
-
Amsterdam, 네덜란드, 1066 CX
- Antoni van Leeuwenhoek
-
Groningen, 네덜란드, 9713 GZ
- Universitair Medisch Centrum Groningen
-
Leidschendam, 네덜란드, 2262 BA
- MC Haaglanden Lok Antoniushove - Afd.Interne - INT
-
Nieuwegein, 네덜란드, 3430EM
- St. Antonius Ziekenhuis (St. Antonius Hospital)
-
Nijmegen, 네덜란드, 6532 SZ
- Canisius-Wilhelminaziekenhuis
-
Rotterdam, 네덜란드, 3075 EA
- Erasmus MC
-
Sittard-Geleen, 네덜란드, 6162 BG
- Zuyderland Medical Center
-
-
-
-
-
Kaohsiung City, 대만, 807
- Kaohsiung Medical University Chung Ho Memorial Hospital
-
Taichung, 대만, 40705
- Taichung Veterans General Hospital
-
Taichung, 대만, 403
- China Medical University Hospital
-
Taichung, 대만, 435
- Tungs' Taichung MetroHarbor Hospital
-
Tainan, 대만, 710
- Chi Mei Medical Center Yong Kang
-
Taipei, 대만, 100
- National Taiwan University Hospital
-
Taipei, 대만, 11217
- Taipei Veterans General Hospital
-
Taoyuan, 대만, 33305
- Chang Gung Memorial Hospital
-
-
-
-
-
Busan, 대한민국, 49241
- Pusan National University Hospital
-
Daegu, 대한민국, 41404
- Kyungpook National University Chilgok Hospital
-
Daegu, 대한민국, 42601
- Keimyung University Dongsan Hospital
-
Daejeon, 대한민국, 35015
- Chungnam National University Hospital
-
Gwangju, 대한민국, 61469
- Chonnam National University Hospital
-
Gyeonggi-do, 대한민국, 10408
- National Cancer Center
-
Gyeonggi-do, 대한민국, 443-721
- Ajou University Hospital
-
Seongnam-si, 대한민국, 13620
- Seoul National University Bundang Hospital
-
Seoul, 대한민국, 03080
- Seoul National University Hospital
-
Seoul, 대한민국, 05505
- Asan Medical Center
-
Seoul, 대한민국, 03722
- Severance Hospital Yonsei University Health System
-
Seoul, 대한민국, 06351
- Samsung Medical Center
-
Seoul, 대한민국, 06591
- The Catholic University of Korea Seoul St Marys Hospital
-
Seoul, 대한민국, 06273
- Gangnam Severance Hospital, Yonsei University Health System
-
-
-
-
-
Braunschweig, 독일, 38126
- Städtisches Klinikum Braunschweig gGmbH - Standort Salzdahlumer
-
Duisburg, 독일, 47179
- Urologicum Duisburg
-
Homburg, 독일, 66424
- Universitätsklinikum des Saarlandes
-
Magdeburg, 독일, 39120
- Universitätsklinikum Otto-von-Guericke-Universität Magdeburg
-
Münster, 독일, 48149
- Universitaetsklinikum Muenster
-
Nürtingen, 독일, 72622
- Studienpraxis Urologie Drs. Feyerabend
-
-
-
-
-
Barnaul, 러시아 제국, 656045
- Altai Regional Oncology Dispensary
-
Ivanovo, 러시아 제국, 153040
- Ivanovo Regional Oncology Dispensary
-
Kursk, 러시아 제국, 305524
- GUZ Kursk Regional Oncology Dispensary
-
Moscow, 러시아 제국, 117997
- Russian Scientific Center of Roentgenoradiology
-
Moscow, 러시아 제국, 125130
- Moscow City Clinical Hospital # 62
-
Nizhny Novgorod, 러시아 제국, 603000
- Clinical Diagnostic Centre of Nizhny Novgorod Region
-
Omsk, 러시아 제국, 644013
- Clinical Oncology Dispensary
-
Pyatigorsk, 러시아 제국, 357500
- LLC Novaya Clinica
-
Pyatigorsk, 러시아 제국, 357502
- Pyatigorsk Interdistrict Oncology Dispensary
-
Saint Petersburg, 러시아 제국, 196603
- Private Medical Institution Euromedservice
-
Saint Petersburg, 러시아 제국, 197758
- Russian Scientific Center of Radiology and Surgical Technologies
-
Saint Petersburg, 러시아 제국, 191104
- Leningrad Regional Oncology Dispensary
-
Saransk, 러시아 제국, 430032
- Republican Oncology Dispensary
-
Sochi, 러시아 제국, 354057
- Oncologic Dispensary No.2
-
Tambov, 러시아 제국, 392013
- Tambov Regional Oncology Clinical Dispansary
-
Tomsk, 러시아 제국, 634050
- Tomsk Cancer Research Institute
-
Tyumen, 러시아 제국, 625000
- Medical-sanitary unit 'Neftyanik'
-
Vologda, 러시아 제국, 160012
- Vologda Regional Oncological Dispensary
-
-
-
-
-
George Town, 말레이시아, 10990
- Hospital Pulau Pinang
-
Johor Bahru, 말레이시아, 81100
- Hospital Sultan Ismail
-
Kota Kinabalu, 말레이시아, 88996
- Hospital Likas
-
Kuala Lumpur, 말레이시아, 50586
- Hospital Kuala Lumpur
-
Kuala Lumpur, 말레이시아, 59100
- University Malaya Medical Centre
-
Kuching, 말레이시아, 93586
- Sarawak General Hospital
-
-
-
-
-
Aguascalientes, 멕시코, 20010
- iBiomed Research Unit
-
Durango, 멕시코, 34000
- Consultorio de Especialidad en Urologia Privado
-
Mexico City, 멕시코, 03100
- Mexico Centre for Clinical Research, S.A. de C.V.
-
Monterrey, 멕시코, 64710
- Avix Investigacion Clinica S C
-
Zapopan, 멕시코, 45040
- Consultorio Privado
-
-
-
-
Alabama
-
Homewood, Alabama, 미국, 35209
- Urology Centers Of Alabama
-
-
Arizona
-
Phoenix, Arizona, 미국, 85054
- Mayo Clinic Arizona
-
Tucson, Arizona, 미국, 85741
- Urological Associates of Southern Arizona, P.C.
-
-
Arkansas
-
Little Rock, Arkansas, 미국, 72211
- Arkansas Urology
-
-
California
-
Riverside, California, 미국, 92505
- Kaiser Permanente
-
San Bernardino, California, 미국, 92404
- San Bernardino Urological Associates
-
San Francisco, California, 미국, 94158
- University of California San Francisco
-
Santa Barbara, California, 미국, 93105
- Sansum Clinic Pharm
-
-
Colorado
-
Denver, Colorado, 미국, 80211
- The Urology Center of Colorado
-
Lakewood, Colorado, 미국, 80228
- Colorado Clinical Research
-
-
Connecticut
-
West Haven, Connecticut, 미국, 06516
- VA Connecticut Healthcare
-
-
Florida
-
Bay Pines, Florida, 미국, 33744
- Bay Pines VA Healthcare System
-
Daytona Beach, Florida, 미국, 32114
- Advanced Urology Institute
-
Jacksonville, Florida, 미국, 32209
- University of Florida Health Jacksonville
-
Jacksonville, Florida, 미국, 32224
- Mayo Clinic - Division Of Hematology/oncology
-
-
Illinois
-
Hines, Illinois, 미국, 60141
- Veterans Affairs Medical Ctr
-
-
Indiana
-
Fort Wayne, Indiana, 미국, 46825
- Fort Wayne Medical Oncology and Hematology
-
Jeffersonville, Indiana, 미국, 47130
- First Urology
-
-
Kansas
-
Kansas City, Kansas, 미국, 66160
- University of Kansas Medical Center
-
-
Kentucky
-
Louisville, Kentucky, 미국, 40202
- Norton Healthcare
-
-
Louisiana
-
New Orleans, Louisiana, 미국, 70121
- Ochsner Clinic Foundation
-
-
Maryland
-
Bethesda, Maryland, 미국, 20817
- Rcca Md, Llc
-
Towson, Maryland, 미국, 21204
- Chesapeake Urology Research Associates
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02114
- Massachusetts General
-
-
Michigan
-
Troy, Michigan, 미국, 48084
- Michigan Institute of Urology
-
-
Missouri
-
Kansas City, Missouri, 미국, 64128
- Kansas City Veterans Affairs Medical Center
-
-
Nebraska
-
Omaha, Nebraska, 미국, 68130
- Nebraska Cancer Specialists
-
Omaha, Nebraska, 미국, 68114
- Adult Pediatric Urology & Urogynecology, P.C
-
-
Nevada
-
Las Vegas, Nevada, 미국, 89169
- Comprehensive Cancer Centers of Nevada
-
-
New Jersey
-
Mount Laurel, New Jersey, 미국, 08054
- Delaware Valley Urology, LLC
-
-
New York
-
Albany, New York, 미국, 12208
- New York Oncology Hematology
-
New York, New York, 미국, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, 미국, 10029
- Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg
-
Syracuse, New York, 미국, 13210
- Upstate Cancer Center
-
-
Ohio
-
Middleburg Heights, Ohio, 미국, 44130
- Helios Clinical Research, LLC
-
-
Oregon
-
Springfield, Oregon, 미국, 97477
- Oregon Urology Institute
-
-
Pennsylvania
-
Bala-Cynwyd, Pennsylvania, 미국, 19004
- MidLantic Urology
-
Lancaster, Pennsylvania, 미국, 17604
- Lancaster Urology
-
Pittsburgh, Pennsylvania, 미국, 15240
- VA Pittsburgh
-
-
South Carolina
-
Myrtle Beach, South Carolina, 미국, 29572
- Carolina Urologic Research Center
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37209
- Urology Associates
-
-
Texas
-
Houston, Texas, 미국, 77030
- University of Texas MD Anderson Cancer Center
-
Houston, Texas, 미국, 77027
- Houston Metro Urology
-
-
Utah
-
Salt Lake City, Utah, 미국, 84106
- Utah Cancer Specialists
-
-
Virginia
-
Salem, Virginia, 미국, 80113
- Salem VA Medical Center
-
Virginia Beach, Virginia, 미국, 23462
- Urology of Virginia, PLCC
-
-
Washington
-
Tacoma, Washington, 미국, 98405
- NorthWest Medical Specialties, PLLC
-
-
-
-
-
Aalst, 벨기에, 9300
- OLV Ziekenhuis Aalst
-
Antwerp, 벨기에, 2610
- ZAS Augustinus
-
Charleroi, 벨기에, 6000
- Grand Hopital de Charleroi, site Notre Dame
-
Ghent, 벨기에, 9000
- AZ Maria Middelares
-
Liège, 벨기에, B-4000
- Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman
-
Merksem, 벨기에, 2170
- ZNA Jan Palfijn
-
-
-
-
-
Burgas, 불가리아, 8001
- MHAT Deva Maria
-
Pleven, 불가리아, 5800
- UMHAT 'Dr. Georgi Stranski', EAD
-
Plovdiv, 불가리아, 4004
- Complex Oncology Center - Plovdiv EOOD
-
Sofia, 불가리아, 1756
- Specialized Hospital for Active Treatment in Oncology EAD
-
Varna, 불가리아, 9010
- SHATOD 'Dr. Marko Antonov Markov'
-
Vratsa, 불가리아, 3001
- Comprehensive Cancer Center
-
-
-
-
-
Barretos, 브라질, 14784-400
- Fundacao Pio XII
-
Belo Horizonte, 브라질, 30130-090
- PERSONAL Oncologia de Precisao e Personalizada
-
Brasília, 브라질, 7020-730
- Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
-
Curitiba, 브라질, 80810 050
- CIONC Centro Integrado de Oncologia de Curitiba
-
Fortaleza, 브라질, 60 810180
- Pronutrir
-
Goiânia, 브라질, 74605-070
- Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
-
Ijuí, 브라질, 98700-000
- Oncosite - Centro de Pesquisa Clínica em Oncologia Ltda
-
Ipatinga, 브라질, 35162 189
- Fundacao Sao Francisco Xavier
-
Joinville, 브라질, 89201-260
- Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia
-
Maceió, 브라질, 57052-765
- Medradius Clinica de Medicina Nuclear e Radiologia de Maceio Ltda.
-
Natal, 브라질, 59062 000
- Liga Norte Riograndense Contra O Cancer
-
Porto Alegre, 브라질, 90020-090
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Porto Alegre, 브라질, 90160-093
- Hospital Ernesto Dornelles
-
Rio de Janeiro, 브라질, 20551-030
- Universidade do Estado do Rio de Janeiro - UERJ
-
Rio de Janeiro, 브라질, 22250 905
- Oncoclinicas Rio de Janeiro S A
-
Rio de Janeiro, 브라질, 22775 001
- Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
-
Rio de Janeiro, 브라질, 20230 130
- Ministerio da Saude Instituto Nacional do Cancer
-
Salvador, 브라질, 40050-410
- Hospital Santa Isabel
-
Santo André, 브라질, 09060-650
- CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia
-
Sorocaba, 브라질, 18030-005
- IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
-
São Paulo, 브라질, 04014-002
- Núcleo de Pesquisa São Camilo
-
São Paulo, 브라질, 01236-030
- Instituto de Ensino e Pesquisa São Lucas
-
São Paulo, 브라질, 04502-001
- Instituto D Or de Pesquisa e Ensino IDOR
-
São Paulo, 브라질, 01509 900
- Fundacao Antonio Prudente A C Camargo Cancer Center
-
São Paulo, 브라질, 04039-004
- Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE
-
São Paulo, 브라질, 01246 000
- Fundacao Faculdade de Medicina Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, 브라질, 01221-020
- Irmandade Santa Casa de Misericordia de Sao Paulo
-
São Paulo, 브라질, 01421-000
- Hospital Alemao Oswaldo Cruz
-
Três Lagoas, 브라질, 79601-001
- Instituto Do Cancer Brasil
-
-
-
-
-
Stockholm, 스웨덴, 171 76
- Karolinska Universitetssjukhuset Solna
-
Stockholm, 스웨덴, 11883
- Sodersjukhuset
-
Uppsala, 스웨덴, 751 85
- Akademiska Sjukhuset
-
-
-
-
-
A Coruña, 스페인, 15006
- Hospital Juan Canalejo
-
Barcelona, 스페인, 08025
- Hosp. de La Santa Creu I Sant Pau
-
Barcelona, 스페인, 08003
- Hosp. Del Mar
-
Barcelona, 스페인, 08036
- Hosp Clinic de Barcelona
-
Jerez de la Frontera, 스페인, 11407
- Hosp. de Jerez de La Frontera
-
Madrid, 스페인, 28040
- Hosp. Clinico San Carlos
-
Madrid, 스페인, 28034
- Hosp. Univ. Ramon Y Cajal
-
Málaga, 스페인, 29010
- Hosp Virgen de La Victoria
-
Pozuelo de Alarcón, 스페인, 28223
- Hosp. Quiron Madrid Pozuelo
-
Sabadell, 스페인, 08208
- Corporacio Sanitari Parc Tauli
-
Santander, 스페인, 39008
- Hosp. Univ. Marques de Valdecilla
-
Valencia, 스페인, 46026
- Hosp. Univ. I Politecni La Fe
-
-
-
-
-
Buenos Aires, 아르헨티나, C1118AAT
- Hospital Aleman
-
Buenos Aires, 아르헨티나, C1426AGE
- Centro Oncológico Korben
-
Buenos Aires, 아르헨티나, C1431FWN
- CEMIC Saavedra
-
Ciudad Automoma Buenos Aires, 아르헨티나, C1120AAT
- Centro de Urologia (CDU)
-
Córdoba, 아르헨티나, X5016KEH
- Hospital Privado Centro Medico de Cordoba
-
Córdoba, 아르헨티나, 5000
- Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
-
Mar del Plata, 아르헨티나, B7602CBM
- Hospital Privado de Comunidad
-
Mar del Plata, 아르헨티나, B7600FZN
- Instituto de Investigaciones Clinicas Mar del Plata
-
Pergamino, 아르헨티나, B2700CPM
- Centro de Investigacion Pergamino SA
-
Rosario, 아르헨티나, 2000
- Sanatorio Britanico de Rosario
-
Rosario, 아르헨티나, S2000SDV
- Sanatorio Parque
-
San Salvador de Jujuy, 아르헨티나, Y4600AFW
- ARS Médica
-
-
-
-
-
Blackburn, 영국, BB2 3HH
- Royal Blackburn Hospital
-
Lancaster, 영국, LA1 4RP
- Royal Lancaster Infirmary
-
London, 영국, WC1E 6DD
- UCL Cancer Institute
-
Torquay, 영국, TQ2 7AA
- Torbay Hospital-Devon
-
Truro, 영국, TR1 3LJ
- Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
-
Wolverhampton, 영국, WV10 0QP
- New Cross Hospital
-
-
-
-
-
Cherkasy, 우크라이나, 18009
- CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
-
Dnipo, 우크라이나, 49005
- Ce 'Dnipropetrovsk Regional Clinical Hospital N.A. Mechnikov' of Dnipropetrovsk Rc
-
Dnipro, 우크라이나, 49102
- Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
-
Dnipro, 우크라이나, 49100
- Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council
-
Ivano-Frankivsk, 우크라이나, 76008
- Ivano-Frankivsk Regional Clinical Hospital
-
Khakhiv, 우크라이나, 61070
- Municipal non-profit enterprise 'Regional Center of Oncology'
-
Kharkiv, 우크라이나, 61037
- Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval
-
Kyiv, 우크라이나, 03115
- State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center
-
Kyiv, 우크라이나, 03022
- State Nonprofit Enterprise National Cancer Institute
-
Lviv, 우크라이나, 79010
- University Hospital of SNA Danylo Halytsky LMNU
-
Poltava, 우크라이나, 36024
- ME 'Poltava Regional Clinical Hospital n.a. M.V. Sklifosovsky of the Poltava Regional Council'
-
Uzhhorod, 우크라이나, 88000
- Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal
-
-
-
-
-
Beer Yaakov, 이스라엘, 60930
- Asaf Harofe Medical Center
-
Haifa, 이스라엘, 31096
- Rambam Health Care Campus
-
Petah Tikva, 이스라엘, 49100
- Rabin Medical Center
-
Ramat Gan, 이스라엘, 52621
- Sheba Medical Center Tel Hashomer
-
-
-
-
-
Faenza, 이탈리아, 48018
- AUSL Romagna - Ospedale di Faenza
-
Milan, 이탈리아, 20132
- Ospedale San Raffaele
-
Milan, 이탈리아, 20162
- ASST Grande Ospedale Metropolitano Niguarda
-
Naples, 이탈리아, 80131
- Oncologia Medica A - Ist Naz Tumori G Pascale
-
Padova, 이탈리아, 35128
- Istituto Oncologico Veneto Iov Irccs Padova
-
Parma, 이탈리아, 43126
- Oncologia Medica - Azienda Ospedaliero Universitaria Di Parma
-
Perugia, 이탈리아, 06132
- Ospedale S. Maria Della Misericordia Centro Operativo Studi Clinici SC Oncologia Medica
-
Pisa, 이탈리아, 56126
- Azienda Ospedaliero Universitaria Pisana
-
Roma, 이탈리아, 00168
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Roma, 이탈리아, 128
- Campus Bio Medico di Roma
-
Terni, 이탈리아, 5100
- Azienda Ospedaliera S. Maria Terni
-
Torino, 이탈리아, 10126
- A.O.U. Città della Salute e della Scienza
-
Trento, 이탈리아, 38122
- Ospedale Santa Chiara Trento
-
-
-
-
-
Beijing, 중국, 100730
- Beijing Hospital
-
Beijing, 중국, 100191
- Peking University Third Hospital
-
Beijing, 중국, 100050
- Beijing Friendship Hospital
-
Beijing, 중국, 100034
- Peking University First Hospital
-
Beijing, 중국, 100021
- Cancer Hospital Chinese Academy of Medical Sciences
-
Beijing, 중국, 100142
- Beijing Cancer Hospital of Peking University
-
Chengdu, 중국, 610072
- Sichuan Provincial Peoples Hospital
-
Chongqing, 중국, 400030
- Chongqing University Cancer Hospital
-
Chongqing, 중국, 400025
- Southwest Hospital, The Third Military Medical University
-
Fuzhou, 중국, 350001
- Fujian Medical University Union Hospital
-
Guangzhou, 중국, 510180
- Guangzhou First Municipal People's Hospital
-
Guangzhou, 중국, 510120
- Sun Yat-Sen Memorial Hospital Sun Yat-sen University
-
Nanjing, 중국, 210009
- Jiangsu Cancer Hospital
-
Nanjing, 중국, 210008
- Nanjing Drum Tower Hospital
-
Ningbo, 중국, 315010
- Drug clinical trial ethics committee of Ningbo First Hospital
-
Shanghai, 중국, 200032
- Fudan University Shanghai Cancer Center
-
Shanghai, 중국, 200040
- Huashan Hospital Fudan University
-
Shanghai, 중국, 200001
- Renji Hospital, Shanghai Jiaotong University School of Medicine
-
Shanghai, 중국, 200040
- ShangHai Huadong Hospital
-
Shanghai, 중국, 200240
- The Fifth People's Hospital of Shanghai, Fudan University
-
Suzhou, 중국, 215006
- The First Affiliated Hospital of Soochow University
-
Tianjin, 중국, 300060
- Tianjin Medical University Cancer Hospital
-
Wuhan, 중국, 430014
- The Central Hospital of Wuhan
-
Wuhan, 중국, 430030
- Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Wuxi, 중국, 214023
- Wuxi People s Hospital
-
Xi'an, 중국, 710061
- The First Affiliated Hospital of Xian Jiaotong University
-
-
-
-
-
Hradec Králove, 체코, 500 05
- Fakultni nemocnice Hradec Kralove
-
Liberec, 체코, 460 63
- Krajská nemocnice Liberec
-
Olomouc, 체코, 77900
- Uromedical Center s.r.o.
-
Pardubice, 체코, 53203
- Multiscan s.r.o.
-
Pilsen, 체코, 305 99
- Fakultni nemocnice Plzen, Urologicka klinika
-
Prague, 체코, 120 00
- Urologicka klinika 1 LF UK a VFN
-
Prague, 체코, 140 59
- Thomayerova nemocnice, Onkologicka klinika
-
Uherské Hradiště, 체코, 68668
- Uherskohradistska nemocnice a.s.
-
-
-
-
Alberta
-
Calgary, Alberta, 캐나다, T2V 1P9
- Southern Alberta Institute of Urology / Prostate Cancer Centre
-
-
British Columbia
-
Vancouver, British Columbia, 캐나다, V5Z 4E6
- British Columbia Cancer Agency BCCA Vancouver Centre
-
Victoria, British Columbia, 캐나다, V8R 6V5
- British Columbia Cancer Agency Vancouver Island Centre
-
-
Ontario
-
Hamilton, Ontario, 캐나다, L8N 4A6
- McMaster Institute of Urology
-
Kingston, Ontario, 캐나다, K7L 3N6
- Cancer Centre of Southeastern Ontario (Kingston Regional Cancer Centre)
-
Toronto, Ontario, 캐나다, M5G2M9
- Princess Margaret Cancer Centre University Health Network
-
Toronto, Ontario, 캐나다, M4N 3M5
- Sunnybrook Health Sciences Center
-
-
Quebec
-
Montreal, Quebec, 캐나다, H2X 0A9
- Centre de Recherche du CHUM
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, 캐나다, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
-
Adana, 터키 (Türkiye), 01330
- Cukurova University, Faculty of Medicine
-
Ankara, 터키 (Türkiye), 06200
- Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital
-
Ankara, 터키 (Türkiye), 6560
- Ankara Bilkent Sehir Hastanesi
-
Antalya, 터키 (Türkiye), 07070
- Akdeniz University Medical Faculty
-
Edirne, 터키 (Türkiye), 22030
- Trakya University Medical Faculty
-
Istanbul, 터키 (Türkiye), 34722
- Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi
-
Istanbul, 터키 (Türkiye), 34098
- Istanbul University Cerrahpasa Medical Faculty
-
Istanbul, 터키 (Türkiye), 34147
- Bakirkoy Training and Research Hospital
-
Izmir, 터키 (Türkiye), 35575
- IEU Medical Point Hospital
-
Kocaeli, 터키 (Türkiye), 41380
- Kocaeli University Medical Faculty
-
-
-
-
-
Coimbra, 포르투갈, 3000-075
- Instituto Portugues de Oncologia de Coimbra Francisco Gentil, EPE
-
Coimbra, 포르투갈, 3000-075
- Hospitais da universidade de Coimbra
-
Lisbon, 포르투갈, 1400-038
- Champalimaud Foundation Champalimaud Centre
-
Lisbon, 포르투갈, 1649-035
- Centro Hospitalar Lisboa Norte EPE Hosp. Santa Maria
-
Porto, 포르투갈, 4099-001
- H. Santo António - Centro Hospitalar do Porto
-
-
-
-
-
Bydgoszcz, 폴란드, 85 094
- Szpital Uniwersytecki NR 1 IM Dr Antoniego Jurasza
-
Bydgoszcz, 폴란드, 85 796
- Centrum Onkologii im Prof F Lukaszczyka
-
Gdansk, 폴란드, 80 214
- Uniwersyteckie Centrum Kliniczne
-
Gdynia, 폴란드, 81 519
- Szpitale Pomorskie Sp z o o
-
Lodz, 폴란드, 93-509
- Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
-
Siedlce, 폴란드, 08-110
- Urologica Praktyka Lekarska Adam Marcheluk
-
Szczecin, 폴란드, 70 111
- Pomorski Uniwersytet Medyczny w Szczecinie
-
Warsaw, 폴란드, 02-781
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Wroclaw, 폴란드, 53 413
- Dolnoslaskie Centrum Onkologii
-
-
-
-
-
San Juan, 푸에르토 리코, 00921
- VA Caribbean Healthcare System
-
-
-
-
-
Besançon, 프랑스, 25030
- CHRU De Besancon
-
Bordeaux, 프랑스, 33000
- Institut Bergonie
-
Clermont-Ferrand, 프랑스, 63011
- Centre Jean Perrin
-
Lyon, 프랑스, 69008
- Centre Leon Berard
-
Montpellier, 프랑스, 34298
- Institut Regional du Cancer de Montpellier Val d'Aurelle
-
Nancy, 프랑스, 54100
- Polyclinique de Gentilly
-
Nice, 프랑스, 06189
- Centre Antoine Lacassagne
-
Paris, 프랑스, 75908
- Hopital Europeen Georges-Pompidou
-
Saint-Herblain, 프랑스, 44805
- Institut de Cancerologie de l Ouest ICO
-
Saint-Mandé, 프랑스, 94163
- HIA Begin
-
Strasbourg, 프랑스, 67098
- Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre
-
-
-
-
-
Budapest, 헝가리, 1082
- Semmelweis Egyetem, Urológia Klinika
-
Budapest, 헝가리, 1122
- Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály
-
Debrecen, 헝가리, 4032
- Debreceni Egyetem Klinikai Kozpont
-
Gyula, 헝가리, 5700
- Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
-
Nyíregyháza, 헝가리, 4400
- Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Josa Andras Oktatokorhaz
-
Pécs, 헝가리, 7621
- Uro-Clin Kft.
-
Szeged, 헝가리, 6720
- Szegedi Tudomanyegyetem
-
Szeged, 헝가리, 6725
- Szegedi Tudomanyegyetem 1
-
Szombathely, 헝가리, 9700
- Markusovszky Egyetemi Oktatokorhaz
-
-
-
-
-
Adelaide, 호주, 5000
- Royal Adelaide Hospital
-
Benowa, 호주, 4217
- Pindara Private Hospital
-
Birtinya, 호주, 4575
- Sunshine Coast University Hospital
-
Brisbane, 호주, 4102
- Princess Alexandra Hospital
-
Darlinghurst, 호주, 2010
- St Vincent s Hospital Sydney
-
Hobart, 호주, 7000
- Royal Hobart Hospital
-
Macquarie University, 호주, 2109
- Macquarie University
-
Malvern, 호주, 3144
- Eye Surgery Associates
-
Melbourne, 호주, 3000
- Peter MacCallum Cancer Centre
-
Murdoch, 호주, 6150
- Fiona Stanley Hospital
-
Nedlands, 호주, 6009
- Hollywood Private Hospital
-
Randwick, 호주, 2031
- Prince Of Wales Hospital
-
Wahroonga, 호주, 2076
- Sydney Adventist Hospital
-
Wollongong, 호주, 2500
- Wollongong Private Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
HRR gene alteration (as identified by the sponsor's required assays) as follows:
- Cohort 1: positive for HRR gene alteration
- Cohort 2: not positive for DRD (that is, HRR gene alteration)
- Cohort 3: eligible by HRR status
-
Metastatic disease documented by positive bone scan or metastatic lesions on computed tomography (CT) or magnetic resonance imaging (MRI)
-
Metastatic prostate cancer in the setting of castrate levels of testosterone less than or equal to (<=) 50 nanogram per deciliter (ng/dL) on a gonadotropin releasing hormone analog (GnRHa) or bilateral orchiectomy
-
Able to continue GnRHa during the study if not surgically castrate
-
Score of <= 3 on the brief pain inventory-short form (BPI-SF) question number 3 (worst pain in last 24 hours)
Exclusion Criteria:
- Prior treatment with a poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor
- Systemic therapy (that is, novel second-generation AR-targeted therapy such as enzalutamide, apalutamide, or darolutamide; taxane-based chemotherapy, or more than 4 months of abiraterone acetate plus prednisone [AAP] prior to randomization) in the metastatic castration-resistant prostate cancer (mCRPC) setting; or AAP outside of the mCRPC setting
- Symptomatic brain metastases
- History or current diagnosis of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML)
- Other prior malignancy (exceptions: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, or any other cancer in situ currently in complete remission) <= 2 years prior to randomization, or malignancy that currently requires active systemic therapy
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Cohort 1: Participants with mCRPC and HRR Gene Alteration
Participants with L1 metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alteration will receive combination of niraparib 200 milligrams (mg) or matching placebo and abiraterone acetate (AA) 1000 mg plus prednisone 10 mg. In the open label extension (OLE) phase participants earlier receiving the combination of niraparib and AAP may continue to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg and those receiving placebo and AAP may cross over depending on the outcome of study to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg. |
Participants will receive niraparib 200 mg capsules or tablets once daily.
다른 이름들:
Participants will receive AA 1000 mg tablets once daily. Participants will receive prednisone 10 mg tablets daily. Participants will receive matching placebo once daily. |
|
실험적: Cohort 2: Participants with mCRPC and No HRR Gene Alteration
Participants with L1 mCRPC and no HRR Gene alteration will receive combination of niraparib 200 mg or matching placebo and AA 1000 mg plus prednisone 10 mg. In the OLE phase participants earlier receiving the combination of niraparib and AAP may continue to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg and those receiving placebo and AAP may cross over depending on the outcome of study to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg. |
Participants will receive niraparib 200 mg capsules or tablets once daily.
다른 이름들:
Participants will receive AA 1000 mg tablets once daily. Participants will receive prednisone 10 mg tablets daily. Participants will receive matching placebo once daily. |
|
실험적: Cohort 3 (Open-label): Participants with mCRPC
Participants with mCRPC will receive a new formulation of niraparib 200 mg and AA 1000 mg tablets plus prednisone 10 mg. |
Participants will receive prednisone 10 mg tablets daily. Participants will receive a new formulation of niraparib 200 mg and AA 1000 mg tablets once daily. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Cohort 1: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR)
기간: Up to 32 months
|
As per BICR, rPFS is time interval from the date of randomization to radiographic progression or death, whichever occurred first. Radiographic progression was determined by: (1) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI) as per response evaluation criteria in solid tumors (RECIST) 1.1; (2) Progression of bone lesions observed by bone scan based on prostate cancer working group 3 (PCWG3) criteria. PCWG3 criteria: bone progression was confirmed by subsequent scan greater than or equal to (>=) 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. Confirmatory scan >=2 new lesions indicate progression; scan does not show >=2 new lesions means no progression. If Week 8 scan less than (<) 2 new bone lesions compared to baseline, the initial scan >=2 new lesions compared to Week 8 scan indicates progression if confirmed by subsequent scan >=6 weeks later. |
Up to 32 months
|
|
Cohort 1 Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR)
기간: Up to 32 months
|
As per BICR, rPFS is time interval from the date of randomization to radiographic progression or death, whichever occurred first. Radiographic progression was determined by: (1) progression of soft tissue lesions measured by CT or MRI as per RECIST 1.1; (2) Progression of bone lesions observed by bone scan based on PCWG3 criteria. PCWG3 criteria: bone progression was confirmed by subsequent scan >=6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. Confirmatory scan >=2 new lesions indicate progression; scan does not show >=2 new lesions means no progression. If Week 8 scan <2 new bone lesions compared to baseline, the initial scan >=2 new lesions compared to Week 8 scan indicates progression if confirmed by subsequent scan >=6 weeks later. |
Up to 32 months
|
2차 결과 측정
결과 측정 |
기간 |
|---|---|
|
코호트 1: 전체 생존(OS)
기간: 최대 97개월
|
최대 97개월
|
|
코호트 1: 증상 진행까지의 시간
기간: 최대 97개월
|
최대 97개월
|
|
코호트 1: 세포독성 화학요법 시작까지의 시간
기간: 최대 97개월
|
최대 97개월
|
|
니라파립의 혈장 농도 관찰
기간: 최대 97개월
|
최대 97개월
|
|
관찰된 아비라테론의 혈장 농도
기간: 최대 97개월
|
최대 97개월
|
|
치료로 인한 부작용(TEAE)이 발생한 참가자 수
기간: 최대 96개월
|
최대 96개월
|
|
중증도별 치료 관련 이상반응이 발생한 참가자 수
기간: 최대 96개월
|
최대 96개월
|
|
실험실 수치에 이상이 있는 참가자 수
기간: 최대 96개월
|
최대 96개월
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
간행물 및 유용한 링크
일반 간행물
- Roubaud G, Attard G, Boegemann M, Olmos D, Trevisan M, Antoni L, Pascoe K, Capone C, Van Sanden S, Hashim M, Palmer S, Chi K. Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer. Eur J Cancer. 2024 Sep;209:114183. doi: 10.1016/j.ejca.2024.114183. Epub 2024 Jun 17.
- Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23.
- Rathkopf DE, Roubaud G, Chi KN, Efstathiou E, Attard G, Olmos D, Small EJ, Saad M, Castro E, Kim W, Wu D, Bertzos K, Dibaj S, Zhang J, Francis P, Smith MR. Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial. Eur Urol. 2025 Oct;88(4):359-369. doi: 10.1016/j.eururo.2024.09.003. Epub 2024 Sep 23.
- De Santis M, Breijo SM, Robinson P, Capone C, Pascoe K, Van Sanden S, Hashim M, Trevisan M, Daly C, Reitsma F, van Beekhuizen S, Ruan H, Heeg B, Verzoni E. Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer. Adv Ther. 2024 Aug;41(8):3039-3058. doi: 10.1007/s12325-024-02918-6. Epub 2024 Jul 3.
- Ye D, Saad M, Lee JY, Jung W, Pang ST, Li L, Gurney H, Attard G, Chi KN, Mundle S, Zhuo J, Singh A, Lin Y, Sandhu S. Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study. Int J Urol. 2026 Apr;33(4):e70455. doi: 10.1111/iju.70455.
- Russu A, Hazra A, Tian H, Haddish-Berhane N, Perez Ruixo JJ, Boulton M. Population Pharmacokinetics of Niraparib/Abiraterone Acetate Administered as Single-Agent Combination and Dual-Acting Tablets Plus Prednisone for Metastatic Castration-Resistant Prostate Cancer. Adv Ther. 2025 Apr;42(4):1860-1880. doi: 10.1007/s12325-025-03104-y. Epub 2025 Feb 28.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- CR108534
- 2017 (미국 NIH 보조금/계약)
- 2017-003364-12 (EudraCT 번호)
- 64091742PCR3001 (기타 식별자: Janssen Research & Development, LLC)
- 2023-503254-12-00 (레지스트리 식별자: EUCT number)
- 2023 (미국 NIH 보조금/계약)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .